[F2] Flash Talks (Even No.)

9:40 AM - 9:41 AM JST(12:40 AM - 12:41 AM UTC)

[F-22] Undying cell death: nucleocytosis-associated cell death

*Hideo Negishi^1,2,3,4, Yusuke Wada¹, Yoshitaka Shirasaki⁵, Tomoya Hayashi^1,2,4, Yuji Kubota⁶, Tomio Iwasaki⁷, Mina Kurosawa¹, Tatsuma Ban⁸, Daisuke Muto⁹, Yusuke Suenaga⁹, Taichi Kojima¹, Yuzuki Matsuda¹, Sean Lord Irish¹, Kosuke Dodo^10,11, Toru Suzuki¹², Mai Yamagishi¹³, Burcu Temizoz^1,2,4, Atsushi Yoshimori¹⁴, Chisato Kanai¹⁵, Yoji Nagasaki¹⁶, Masaki Ohmuraya¹⁷, Tomohiko Tamura^8,18, Atsushi Iwama^4,19,20, Toshifumi Inada^4,12, Etsushi Kuroda²¹, Kouji Kobiyama^1,2,4, Noriko Toyama-Sorimachi², Mutsuhiro Takekawa^4,6,22, Cevayir Coban^2,4,23, Ken J Ishii^1,2,4 (1. Department of vaccine science, The UTOPIA Center, The University of Tokyo (Japan), 2. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 3. Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan (Japan), 5. Division of Photonic Imaging, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan (Japan), 6. Division of Cell Signaling and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 7. esearch and Development Group, Hitachi, Ltd., Ibaraki, Japan (Japan), 8. Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan (Japan), 9. Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan (Japan), 10. Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan (Japan), 11. Catalysis and Integrated Research Group, RIKEN Center for Sustainable Resource Science, Saitama, Japan (Japan), 12. Division of RNA and gene regulation, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 13. Live Cell Diagnosis, Ltd., Saitama, Japan (Japan), 14. Institute for Theoretical Medicine, Inc., Kanagawa, Japan (Japan), 15. INTAGE Healthcare, Inc., Osaka, Japan (Japan), 16. Department of Pharmacy, NHO Kyushu Medical Center, Fukuoka, Japan (Japan), 17. Department of Genetics, School of Medicine, Hyogo Medical University, Hyogo, Japan (Japan), 18. Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan (Japan), 19. Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 20. Laboratory of Cellular and Molecular Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (Japan), 21. Department of Immunology, Hyogo Medical University School of Medicine, Hyogo, Japan (Japan), 22. Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 23. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan))

Keywords:

Cell death,Nucleocytosis,IFN

Password required to view

Log in

or